Ajanta Pharma

Rediff.com » News » Ajanta Pharma

News for Ajanta Pharma

News
Business

Volcker's findings: focus now on evidence

After K Natwar Singh was stripped of the external affairs ministry portfolio, the focus is now on the evidence against him and the Congress party, which was also named as one of the non-contractual......

Ajanta Pharma reissues shares

Ajanta Pharma Ltd reissued 250 equity shares, earlier forfeited by the company.BSE code:...

Ajanta Pharma, Medicago join hands for flu vaccine

Mumbai-based Ajanta Pharma has tied up with the Canadian vaccine maker, Medicago Inc, to commercialise Medicago's pandemic and seasonal influenza vaccines in India and other territories. A......

Lower input costs may aid pharma firms' Q2 margins

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and......

India business to put a spring in pharma's step

Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels. Illustration: Uttam Ghosh/Rediff.com Analysts feel that revenue and EBIDTA growth in the pharmaceutical sector......

Largecap, midcap cutoff surges over 26% in latest Amfi classification

The rally in the equity markets in the second half of 2023 has led to a sharp surge in the cutoff for stocks to qualify as largecaps and midcaps. Illustration: Dominic Xavier/Rediff.com On the......

Ajanta Pharma

News for Ajanta Pharma

Volcker's findings: focus now on evidence

Ajanta Pharma reissues shares

Ajanta Pharma, Medicago join hands for flu vaccine

Lower input costs may aid pharma firms' Q2 margins

India business to put a spring in pharma's step

Largecap, midcap cutoff surges over 26% in latest Amfi classification

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS